• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

日本无细胞百日咳疫苗在家庭内接触百日咳患者后的临床疗效。

Clinical efficacy of the Japanese acellular pertussis vaccine after intrafamiliar exposure to pertussis patients.

作者信息

Isomura S, Suzuki S, Sato Y

出版信息

Dev Biol Stand. 1985;61:531-7.

PMID:3914964
Abstract

A major increase in the number of pertussis cases was observed subsequent to the complete discontinuation of mass-immunization against the disease in Aichi Prefecture in central Japan. The discontinuation of DTP vaccine started in 1975 and lasted for five years. Since 1978, epidemics of pertussis were observed in children mainly in the unvaccinated age groups. The outbreaks continued in the following year and subsided in 1980 when vaccination was reintroduced. Since 1981 newly developed acellular pertussis vaccines have been used for mass-immunization. The incidence of pertussis has remained low and no epidemics of the disease have been observed among children vaccinated with the new vaccines. During the epidemics in Aichi Prefecture, the protective efficacy of the new vaccines were studied in 21 vaccinees with intrafamiliar exposure to the disease. Clinical observations showed that the vaccine reduced the attack rate of pertussis after household contacts from 85% to 9.5%. It was concluded that the vaccine effectively prevented pertussis.

摘要

在日本中部爱知县完全停止针对百日咳的大规模免疫接种后,观察到百日咳病例数大幅增加。白喉、破伤风、百日咳(DTP)疫苗的接种停止于1975年,并持续了五年。自1978年以来,百日咳疫情主要在未接种疫苗的年龄组儿童中出现。疫情在次年持续,并在1980年重新引入疫苗接种时平息。自1981年以来,新研发的无细胞百日咳疫苗已用于大规模免疫接种。百日咳发病率一直较低,在接种新疫苗的儿童中未观察到该疾病的疫情。在爱知县疫情期间,对21名在家庭中接触过该疾病的疫苗接种者研究了新疫苗的保护效力。临床观察表明,该疫苗将家庭接触后百日咳的发病率从85%降低到了9.5%。得出的结论是,该疫苗有效预防了百日咳。

相似文献

1
Clinical efficacy of the Japanese acellular pertussis vaccine after intrafamiliar exposure to pertussis patients.日本无细胞百日咳疫苗在家庭内接触百日咳患者后的临床疗效。
Dev Biol Stand. 1985;61:531-7.
2
Results with a new DTP vaccine in Japan.日本新型白喉、百日咳、破伤风联合疫苗的研究结果。
Dev Biol Stand. 1985;61:545-61.
3
Clinical studies on efficacy and safety of an acellular pertussis vaccine in Aichi Prefecture, Japan.日本爱知县无细胞百日咳疫苗有效性和安全性的临床研究。
Dev Biol Stand. 1991;73:37-42.
4
Clinical studies on efficacy and safety of acellular pertussis vaccine.无细胞百日咳疫苗的疗效和安全性临床研究。
Tokai J Exp Clin Med. 1988;13 Suppl:39-43.
5
Pertussis vaccine effectiveness among children 6 to 59 months of age in the United States, 1998-2001.1998 - 2001年美国6至59个月大儿童的百日咳疫苗效力
Pediatrics. 2005 Aug;116(2):e285-94. doi: 10.1542/peds.2004-2759.
6
Protection against pertussis by Takeda's acellular pertussis vaccine: household contact studies in Kawasaki City, Japan.
Tokai J Exp Clin Med. 1988;13 Suppl:35-8.
7
Calculation of efficacy of acellular pertussis vaccine from the number of pertussis patients and vaccinees in three areas.根据三个地区百日咳患者数量和疫苗接种者数量计算无细胞百日咳疫苗的效力
Dev Biol Stand. 1991;73:43-9.
8
Clinical and serological reactions after immunization of children in Ghana, West Africa, with the Japanese acellular pertussis vaccine.在西非加纳,儿童接种日本无细胞百日咳疫苗后的临床和血清学反应。
Dev Biol Stand. 1985;61:539-43.
9
Whole-cell and acellular pertussis vaccination programs and rates of pertussis among infants and young children.全细胞和无细胞百日咳疫苗接种计划以及婴幼儿百日咳发病率
CMAJ. 2006 Nov 7;175(10):1213-7. doi: 10.1503/cmaj.051637.
10
Long-term follow-up of Swedish children vaccinated with acellular pertussis vaccines at 3, 5, and 12 months of age indicates the need for a booster dose at 5 to 7 years of age.对瑞典在3、5和12月龄接种无细胞百日咳疫苗的儿童进行长期随访表明,5至7岁时需要加强一剂疫苗。
Pediatrics. 2006 Sep;118(3):978-84. doi: 10.1542/peds.2005-2746.